Alzheimer's disease

News

Linus Health grows in dementia with Together acquisition

Linus Health, a specialist in digital detection of dementia, has expanded its focus to include the treatment of patients with the acquisition of Together Senior Health.

News

Novo leads $100m financing for Alzheimer's player Asceneuron

Novo Nordisk's parent company, Novo Holdings, has led a $100 million third-round financing for Swiss biotech Asceneuron, which is developing a non-amyloid therapy for Alzheimer's disease.

News

Ozempic’s latest health benefit may be cutting dementia risk

Another week, and another study has emerged pointing to a way that GLP-1 receptor agonists may benefit human health.

News

Lilly gets FDA OK for Alzheimer’s drug, cites cost advantage

Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease therapy donanemab and will launch it at a cost it claims could deliver savings compared to a rival therapy fro

News

ALZpath licenses Alzheimer’s diagnosis tech to Roche

Diagnostics giant Roche is putting its weight behind a biomarker for Alzheimer’s disease developed by ALZpath.

News

Lilly’s Alzheimer’s drug set to join Leqembi after FDA vote

An FDA advisory committee has delivered a strong endorsement to Eli Lilly’s Alzheimer’s disease therapy donanemab, voting unanimously that the safety and efficacy of the amyloid-busti

Linus Health grows in dementia with Together acquisition

Novo leads $100m financing for Alzheimer's player Asceneuron

Ozempic’s latest health benefit may be cutting dementia risk

Lilly gets FDA OK for Alzheimer’s drug, cites cost advantage

ALZpath licenses Alzheimer’s diagnosis tech to Roche

Lilly’s Alzheimer’s drug set to join Leqembi after FDA vote

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Alzheimer's disease

Editor's Picks